𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of βrenergic Blockade with Propranolol in Patients with Cirrhosis

✍ Scribed by Eric Bercoff; Christian Bataille; Alexandre E. Pariente; Dominique Valla; Brigitte Delhotal; Didier Lebrec

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
352 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

β-Blockade with propranolol and hepatic
β-Blockade with propranolol and hepatic artery blood flow in patients with cirrhosis
✍ Ricardo Mastai; Dr. Jaime Bosch; Jordi Bruix; Miguel Navasa; David Kravetz; Juan 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

In patients with cirrhosis and portal hypertension, propranolol administration reduces heart rate and cardiac output and diminishes portal pressure and collateral blood flow. However, there is little information on the possible effects of propranolol on hepatic artery blood flow. The present study a

Noninvasive assessment of portal hyperte
Noninvasive assessment of portal hypertension in patients with cirrhosis
✍ Dominique Thabut; Richard Moreau; Didier Lebrec 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Severe portal hypertension is responsible for complications and death. Although measurement of the hepatic venous pressure gradient is the most accurate method for evaluating the presence and severity of portal hypertension, this technique is considered invasive and is not routinely performed in all

Effects of propranolol on the hepatic he
Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis
✍ Juan-Carlos Bandi; Joan Carles García-Pagán; Angels Escorsell; Erik François; Ed 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Physical exercise increases portal pressure (hepatic venous pressure gradient [HVPG]) in patients with cirrhosis. It is unknown if this deleterious effect is associated with changes in gastroesophageal collateral blood flow and if these can be prevented by propranolol administration. The aim of

Pharmacokinetics of diacerein in patient
Pharmacokinetics of diacerein in patients with liver cirrhosis
✍ O. Magnard; K. Louchahi; M. Tod; O. Petitjean; P. Molinier; L. Berdah; G. Perret 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The pharmacokinetics of diacerein following a single oral dose of 50 mg was studied in 12 healthy volunteers, 10 patients with a mild liver cirrhosis (Child Pugh's grade A), and 6 patients with a more severe liver cirrhosis (Child Pugh's grade B to C). Statistical analysis using a Kruskal-Wallis tes